Member Info for Trombone

Very rude osd, soup knows more than most about nfx. Might pay you to listen a bit more and speak a bit less

Tyco, or Johnson Controls also have a footprint in healthcare. You need to research a little deeper. The licence agreement fits their profile very well

Some of us have been stuck here for years waiting for the various BOD to do something positive for shareholders unlike the Johnny come latelys who have brought their ridiculous ramping to this chat in recent days.

What a typically stupid post littleted! Do make some attempt to act like a grown up

Nicko, you could have omitted the last 5 words

Enzo complete or+t

And if news doesn't drop it will plunge right back down again. The SP is at the mercy of pump and dump traders at the moment, not helped by the radio silence from Dan

A company who have been talking up a deal for it's lead asset for 8 years and still no closer to one as far as is known, who have changed the management team more often than Chelsea, who have almost run out of money again, and who have regularly shafted investors with placings are criminally undervalued in your opinion 🤔

Or the buyer is genuinely not in a position to disclose the deal!!

thanks littleted and bpo****ive, your pharmaceutical knowledge and insights have greatly enhanced the bb. bath time for you now i think

The link between AZ and IPF are credible but that doesn't mean AZ are interested in NXP002 ! Dan has in the past stated that major pharma are not keen on repurposed drugs and that mid tier pharma would be the more likely partners.

No amount of baseless ramping is likely to change that

Right, I've "loaded up" with my buy of £23-56, when does the AZ £1 party start?

FFS the ramping clowns are back. Where do all these idiots come from?

This company resembles the journey of the Marie Celeste; ghostly crew , aimless drifting and mostly in complete silence

FFS give over Mannan, your incessant ramping isn't just boringly stupid. You're way off the mark every time

Dan Gooding has already stated that major pharma won't be interested and it's much more likely that a mid tier pharma will take 002 onwards

I know Kevin and can categorically state he didn't get any free shares

Garbage

The product isn't marketable. It has the potential to be but at the present time it's not. Marketing is years and many millions of $$ away

Mannan and MillonAir- the Laurel and Hardy of LSE